The Ministry of External Affairs on Friday said that India is closely monitoring the impact of US President Donald Trump’s announcement to impose tariffs of up to 100% on imports of branded and patented pharmaceutical drugs, effective from October 1, 2025.

In a weekly briefing, MEA Spokesperson Randhir Jaiswal said that relevant ministries and departments are monitoring the situation and examining its potential effects.

“We saw a notice yesterday on social media that talked about new tariffs. We’ve seen the report on pharma and other products, and the relevant ministry and department are closely monitoring the matter and examining its impact,” Jaiswal said.

The tariffs specifically target branded and patented pharmaceuticals, potentially affecting multinational pharmaceutical companies.

See Full Page